Foreign firms deny trials caused deaths in India amid concerns over reporting norms
This article was originally published in Scrip
Executive Summary
Multinationals undertaking clinical trials in India such as Novartis, Merck & Co and the biopharmaceutical services company, Quintiles, have refuted claims that their studies have caused several deaths. The companies caution that any knee-jerk reaction to tighten policy irrationally may also hurt large non-industry-sponsored trials for developing world diseases in the country.